Tag

Opvee

All articles tagged with #opvee

health2 years ago•5 min saved

"Extended Duration: FDA-Approved Nasal Spray Reverses Opioid Overdoses with Opvee"

Indivior has begun shipping its newly approved overdose reversal medication, Opvee, to first responders and pharmacies. Opvee is a nasal spray version of the drug nalmefene and is designed to quickly reverse the effects of an opioid overdose by blocking opioid receptors in the brain. The drug is being marketed as a potent "fentanyl fighter" due to its longer-lasting formulation, which is better suited to combat the powerful synthetic opioid. However, concerns about affordability and potential withdrawal symptoms for users have been raised. The market for overdose reversal drugs is becoming increasingly crowded, with other options such as Narcan and RiVive also available.

via USA TODAY|

#fentanyl #health #naloxone

health3 years ago•6 min saved

FDA approves new nasal spray to reverse opioid overdoses.

The FDA has approved Opvee, a nasal-spray medication that can reverse overdoses caused by synthetic opioids, including fentanyl. However, some public health experts, physicians, and community groups are concerned about the cost and potential side effects of the drug. Opvee is a more potent medication than naloxone, which is widely used to reverse overdoses, and may cause agonizing, long-lasting withdrawal symptoms for some drug users after they are revived. Critics argue that cheaper, proven medications such as naloxone are sufficient to combat overdose deaths.

via The Washington Post|

#fda #health #naloxone

health3 years ago•4 min saved

FDA approves nasal spray to reverse opioid overdoses.

The FDA has approved Opvee, a nasal spray version of the drug nalmefene, to reverse overdoses caused by fentanyl and other opioids. Developed by Opiant Pharmaceuticals and recently acquired by Indivior, Opvee is similar to naloxone and is approved for patients 12 and older. While Opvee achieved similar recovery results to Narcan in studies, some experts see potential downsides to its longer-acting effect, including longer-lasting withdrawal symptoms. The drug will compete in the same market as naloxone, where most buyers are local governments and community groups that distribute to first responders and those at risk of overdose.

via NPR|

#fda #health #indivior

health3 years ago•3 min saved

FDA approves new opioid overdose treatments.

The FDA has approved Opvee, a nasal spray version of the drug nalmefene, to reverse overdoses caused by fentanyl and other opioids. Opvee is similar to naloxone, which has been used for decades to counter overdoses of opioids. The drug will be available via prescription and is approved for patients 12 and older. Some experts see potential downsides to its longer-acting effect, including intense withdrawal symptoms lasting six hours or more. The drug will compete in the same market as naloxone, where most buyers are local governments and community groups that distribute to first responders and those at risk of overdose.

via Yahoo! Voices|

#fda #health #indivior